Protalix BioTherapeutics, Inc. (DE) (PLX) Social Stream



Protalix BioTherapeutics, Inc. (DE) (PLX): $1.29

0.01 (+0.39%)

POWR Rating

Component Grades

Momentum

C

Stability

C

Sentiment

Quality

C

Add PLX to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#51 of 329

in industry

PROTALIX BIOTHERAPEUTICS INC (PLX) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering PLX.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2022-04-05 1 $11 $7 $9 $1.74 417.24%
2023-08-08 1 $16 $16 $16 $1.74 819.54%
2023-11-07 1 $16 $10 $13 $1.74 647.13%

Price Target Last Issued April 5, 2022

The Trend in the Analyst Price Target


Over the past 91 days, PLX's average price target has gone down $3.

PLX reports an average of 734.16% for its upside potential over the past 91 days.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-08-08 1 16 16 16 1.92 733.33%
2023-11-01 1 16 10 13 1.62 702.47%
2023-11-07 1 16 10 13 1.50 766.67%

PLX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 1 0 0 0 0 1

The Trend in the Broker Recommendations


Over the past 92 days, PLX's average broker recommendation rating improved by 0.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • PLX has a greater number of analysts covering the stock than nearly none of all US stocks.
  • PROTALIX BIOTHERAPEUTICS INC's upside potential (average analyst target price relative to current price) is higher than 382.83% of stocks in the mid market cap category.
  • In the context of Pharmaceutical Products stocks, PROTALIX BIOTHERAPEUTICS INC's variance in analysts' estimates is lower than 41.04% of them.
  • PROTALIX BIOTHERAPEUTICS INC's average analyst price target is higher than 59.39% of stocks in the mid market cap category.

Stocks similar to PROTALIX BIOTHERAPEUTICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are EDIT, FATE, and NSTG.

What is the outlook for PLX? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!